Morgan Stanley’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.5M Sell
2,687,299
-246,100
-8% -$5.86M ﹤0.01% 1821
2025
Q4
$68.5M Buy
2,933,399
+1,089,775
+59% +$24.3M ﹤0.01% 1777
2025
Q3
$36.3M Sell
1,843,624
-1,339,899
-42% -$27.6M ﹤0.01% 2302
2025
Q2
$69.1M Buy
3,183,523
+788,968
+33% +$18.6M ﹤0.01% 1630
2025
Q1
$58.1M Buy
2,394,555
+306,505
+15% +$6.9M ﹤0.01% 1687
2024
Q4
$43.6M Buy
2,088,050
+264,776
+15% +$5.69M ﹤0.01% 1958
2024
Q3
$36.2M Buy
1,823,274
+810,595
+80% +$15M ﹤0.01% 2172
2024
Q2
$15.7M Sell
1,012,679
-786,177
-44% -$12.2M ﹤0.01% 2926
2024
Q1
$28.7M Sell
1,798,856
-2,124,222
-54% -$32M ﹤0.01% 2296
2023
Q4
$65.9M Buy
3,923,078
+3,009,983
+330% +$41.1M ﹤0.01% 2154
2023
Q3
$10.7M Buy
913,095
+19,027
+2% +$255K ﹤0.01% 3077
2023
Q2
$12M Sell
894,068
-534,245
-37% -$7.69M ﹤0.01% 2995
2023
Q1
$23.7M Sell
1,428,313
-309,090
-18% -$5.1M ﹤0.01% 2236
2022
Q4
$32.3M Buy
1,737,403
+173,258
+11% +$2.67M ﹤0.01% 1894
2022
Q3
$20.1M Buy
1,564,145
+112,883
+8% +$1.34M ﹤0.01% 2186
2022
Q2
$10.2M Buy
1,451,262
+209,936
+17% +$1.54M ﹤0.01% 3048
2022
Q1
$10.3M Buy
1,241,326
+976,218
+368% +$6.9M ﹤0.01% 2882
2021
Q4
$1.79M Buy
265,108
+43,508
+20% +$286K ﹤0.01% 4663
2021
Q3
$1.18M Sell
221,600
-123,817
-36% -$677K ﹤0.01% 4950
2021
Q2
$1.99M Buy
345,417
+253,903
+277% +$1.31M ﹤0.01% 4644
2021
Q1
$422K Sell
91,514
-74,661
-45% -$297K ﹤0.01% 5246
2020
Q4
$555K Sell
166,175
-2,613,902
-94% -$8.78M ﹤0.01% 5016
2020
Q3
$8.26M Sell
2,780,077
-39,958
-1% -$156K ﹤0.01% 2203
2020
Q2
$13M Buy
2,820,035
+107,406
+4% +$483K ﹤0.01% 1741
2020
Q1
$10.4M Sell
2,712,629
-150,696
-5% -$619K ﹤0.01% 1730
2019
Q4
$10.7M Buy
2,863,325
+222,356
+8% +$1.04M ﹤0.01% 2366
2019
Q3
$14M Buy
2,640,969
+118,668
+5% +$632K ﹤0.01% 1794
2019
Q2
$9.69M Buy
2,522,301
+210,511
+9% +$909K ﹤0.01% 2198
2019
Q1
$11.8M Sell
2,311,790
-937,883
-29% -$2.76M ﹤0.01% 1869
2018
Q4
$6.24M Buy
3,249,673
+1,502,771
+86% +$4.3M ﹤0.01% 2630
2018
Q3
$6.6M Buy
1,746,902
+4,428
+0.3% +$13.9K ﹤0.01% 2881
2018
Q2
$5.44M Buy
1,742,474
+557,090
+47% +$1.69M ﹤0.01% 3055
2018
Q1
$2.83M Buy
1,185,384
+334,250
+39% +$1.11M ﹤0.01% 3654
2017
Q4
$3.33M Buy
851,134
+486,096
+133% +$1.61M ﹤0.01% 3529
2017
Q3
$920K Buy
365,038
+266,264
+270% +$730K ﹤0.01% 4487
2017
Q2
$273K Buy
98,774
+72,429
+275% +$151K ﹤0.01% 5158
2017
Q1
$52K Buy
26,345
+13,926
+112% +$17.7K ﹤0.01% 5816
2016
Q4
$13K Buy
12,419
+10,212
+463% +$11.7K ﹤0.01% 6098
2016
Q3
$2K Sell
2,207
-4,427
-67% -$3.99K ﹤0.01% 6362
2016
Q2
$5K Sell
6,634
-806
-11% -$649 ﹤0.01% 6215
2016
Q1
$9K Sell
7,440
-18,297
-71% -$28.4K ﹤0.01% 6156
2015
Q4
$64K Sell
25,737
-21,571
-46% -$61.8K ﹤0.01% 5618
2015
Q3
$142K Sell
47,308
-323,205
-87% -$1.39M ﹤0.01% 5253
2015
Q2
$1.53M Sell
370,513
-400,218
-52% -$1.6M ﹤0.01% 3864
2015
Q1
$3.34M Buy
770,731
+108,973
+16% +$393K ﹤0.01% 3126
2014
Q4
$1.97M Sell
661,758
-574,421
-46% -$1.58M ﹤0.01% 3581
2014
Q3
$4.1M Buy
+1,236,179
New +$3.23M ﹤0.01% 2799
2014
Q2
Sell
-3,161
Closed -$7K 6527
2014
Q1
$7K Sell
3,161
-5,540
-64% -$11.6K ﹤0.01% 6185
2013
Q4
$17K Buy
+8,701
New +$17.6K ﹤0.01% 5907

Other funds holding CPRX